Planview and Ozmosi: Bringing AI-Powered Insight to Pharmaceutical Portfolio Decisions

Pharmaceutical organizations are under increasing pressure to make faster, smarter R&D decisions in an environment defined by complexity, uncertainty, and constant change. Making the environment even more vulnerable – and volatile – is the looming “patent cliff” for some of the world’s best-selling drugs, which some analysts predict will trigger up to $350 billion in losses by 2032, according to CNBC.

Four Demand Intake Criteria That Improve Portfolio Prioritization

Portfolio leaders are expected to make confident investment decisions under tight timelines and competing priorities. They are often faced with a growing pipeline of initiatives, each competing for limited capacity and positioned as important. Some proposals are well-defined, grounded in clear outcomes and business context. Many are not. Yet the expectation remains the same: evaluate,…

A Scrapbook of Past Projects

Enterprise Architecture has a reputation problem. Not because it lacks rigor or structure — quite the opposite. But because too often, architecture feels like something that exists next to the organization rather than within it. Diagrams live in tools, standards sit in documents, and architectural knowledge slowly fragments across folders, platforms, and people’s heads. It’s kind of like an intangible scrapbook of past projects.
The Architecture Repository, as described in the TOGAF® Standard, is an attempt to fix that. Not by introducing yet another tool or database, but by introducing a way of thinking. A way of treating architecture as a coherent, evolving body of knowledge — one that can be reused, governed, and continuously refined.

The post A Scrapbook of Past Projects appeared first on EAWheel.